INFO:

From the 2023 San Antonio Breast Cancer Symposium (SABCS), Patient Power is joined by Aditya Bardia, MD, MPH, breast oncologist, Massachusetts General Hospital, to discuss the current standard of care for patients with high-risk early-stage HR-positive/HER2-negative breast cancer and which patients are candidates for treatment with immune checkpoint inhibitors.